AIM ImmunoTech Depreciation & Amortization 2011-2026 | AIM

Annual Depreciation & Amortization AIM ImmunoTech

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
38 K	659 K	665 K	735 K	856 K	948 K	1.12 M	941 K	665 K	671 K	643 K	465 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.12 M	38 K	700 K

Quarterly Depreciation & Amortization AIM ImmunoTech

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	10 K	-	-	-	9 K	-	-	-	11 K	-	29 K	20 K	10 K	-	484 K	325 K	162 K	-	500 K	340 K	173 K	-	557 K	380 K	194 K	-	658 K	444 K	216 K	-	739 K	504 K	261 K	-	854 K	576 K	300 K	-	663 K	458 K	180 K	-	500 K	332 K	167 K	-	504 K	350 K	179 K	-	469 K	296 K	149 K	-	322 K	198 K	112 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
854 K	9 K	324 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Processa Pharmaceuticals PCSA	1.2 K	$ 2.3	-1.29 %	$ 3.01 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Amphastar Pharmaceuticals AMPH	31.6 M	$ 19.57	1.77 %	$ 915 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Phathom Pharmaceuticals PHAT	633 K	$ 10.47	4.08 %	$ 763 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	142 M	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	28 M	-	-	$ 546 M	USA
Cara Therapeutics CARA	259 K	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Pliant Therapeutics PLRX	1.7 M	$ 1.31	2.34 %	$ 80.4 M	USA
PMV Pharmaceuticals PMVP	133 K	$ 1.37	-1.44 %	$ 72 M	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.33	0.76 %	$ 339 M	Britain
Corbus Pharmaceuticals Holdings CRBP	233 K	$ 8.31	1.59 %	$ 111 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 47.09	1.42 %	$ 4.23 B	Schweiz
Cyclacel Pharmaceuticals CYCC	6 K	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	3.14 M	-	-	$ 3.74 B	USA
Prelude Therapeutics Incorporated PRLD	1.71 M	$ 3.26	4.49 %	$ 251 M	USA
Dynavax Technologies Corporation DVAX	4.63 M	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	140 K	-	-4.8 %	$ 255 M	USA
Enochian Biosciences ENOB	129 K	-	-	$ 40.5 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Palatin Technologies PTN	259 K	$ 21.0	5.79 %	$ 19.5 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Pulmatrix PULM	106 K	$ 2.12	-1.4 %	$ 7.74 M	USA
Arbutus Biopharma Corporation ABUS	363 K	$ 4.53	5.1 %	$ 868 M	Canada
Homology Medicines FIXX	391 K	-	0.77 %	$ 53.4 M	USA